Clinical Cancer Center

New York, New York 10029

0 studies enrolling now · 3 studies all time

What they study most

Metastatic Androgen Independent Prostate Cancer, Pancreatic Cancer, Prostate Cancer

Studies at this site

• A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer — Running, not enrolling
• Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) — Completed
• Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed